Global trends, potential mechanisms and early detection of organ damage in SLE

Anselm Mak1, David A Isenberg, Chak-Sing Lau

  • 1Division of Rheumatology, Department of Medicine, University Medicine Cluster, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Level 10, NUHS Tower Block, Singapore 119228. mdcam@nus.edu.sg

Insights

Systemic lupus erythematosus (SLE) patients are living longer, but chronic organ damage, especially cardiovascular, neuropsychiatric, and renal, limits survival. Early detection and treatment of this damage are crucial for improving longevity in SLE patients.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Increasing longevity in Systemic Lupus Erythematosus (SLE) patients has shifted focus to chronic organ damage.
  • Cardiovascular, neuropsychiatric, and renal damage are significant contributors to morbidity and mortality in SLE.
  • Current strategies focus on acute injury, necessitating a parallel approach for managing chronic damage.

Purpose of the Study:

  • To review the global patterns and trends of organ damage in SLE.
  • To explore potential serological and genetic mechanisms underlying SLE-related organ damage.
  • To discuss advancements in early detection tools for SLE organ damage.

Main Methods:

  • Meta-analysis of over 70 observational studies.
  • Worldwide lupus center observations.
  • Review of current research on diagnostic tools and risk models.

Main Results:

  • Organ damage, particularly cardiovascular, has increased over the past four decades.
  • Neuropsychiatric and renal damage remain key factors limiting survival in SLE.
  • Early diagnosis and immunosuppression are vital for acute injury, but chronic damage management is key for long-term survival.

Conclusions:

  • Managing chronic organ damage is essential for improving survival in SLE patients.
  • Early detection and timely treatment of organ damage, alongside meticulous monitoring, are critical.
  • Advances in imaging, biomarkers, and risk models offer promise for early detection of SLE-related organ damage.

Related Concept Videos